News | June 25, 2012

First ACE Accreditations Highlight Common Problem Areas in Cath Labs  

Incomplete records complicate evaluations of patient risk, PCI appropriateness

June 25, 2012 — The first 10 cardiac catheterization laboratories to undergo review by Accreditation for Cardiovascular Excellence (ACE) all welcomed the evaluation by outside experts. Still, review teams found insufficiencies in record-keeping and other quality metrics at well-run medical centers, according to two studies presented at the recent Society for Cardiovascular Angiography and Interventions (SCAI) 2012 Scientific Sessions.

Among the shortcomings found by the ACE review teams were medical records missing key clinical information, cardiac catheterization reports lacking data needed to determine patient risk and inconsistent use of random case reviews as a tool for ensuring quality and appropriateness. A significant amount of variation in documentation among sites was also seen during these reviews.

ACE accredits facilities that perform invasive cardiovascular procedures such as cardiac catheterization and percutaneous coronary intervention (PCI). The nonprofit organization, which was launched in May 2009 with support from SCAI and the American College of Cardiology Foundation, issued its first accreditation in May 2011.

As reported in the first study presented at SCAI, investigators gathered data on quality processes from the first 10 medical centers to undergo ACE review. They examined a total of 441 medical records from patients who underwent cardiac catheterization, PCI or both.

In the study, more than 93 percent of charts earned good marks for the completeness of most clinical data. However, certain areas needed improvement. Radiation exposure was documented in only 87 percent, and a combination of X-ray exposure time and absorbed radiation dose in 77.5 percent.

In addition, information on the severity of chest pain (angina class) was present in 28 percent of records, the extent of the risk associated with the patient’s coronary artery disease based on stress testing was stated in 8 percent and the patient’s functional status (New York Heart Association class) was stated in 21.8 percent of records. Other clinical information needed by the National Cardiovascular Data Registry (NCDR) to assess the risk of patients treated with PCI was missing from many records, making it difficult for reviewers to validate the accuracy of the data submitted to the database.

For the second study presented at SCAI 2012, physician reviewers from ACE examined 478 randomly selected angiograms and the accompanying cath reports from the same 10 facilities. They found that the results of PCI were adequate in 89 percent of cases. However, cath reports often contained insufficient or unclear information on patient risk and the appropriateness of PCI. For example, evidence that the patient’s heart muscle was not getting enough blood and oxygen (ischemia) was documented in only 46 percent of patients. About 8 percent of patients had intravascular ultrasound or another test to determine whether PCI was needed, but half of these studies were inadequate or indeterminate, and documentation was poor.

Overall, only 66 percent of non-urgent PCIs could be deemed appropriate based on the angiogram and information available in the cath report. In 26 percent of cases the appropriateness of PCI was considered uncertain primarily because of the limited documentation, while 8 percent of procedures were deemed inappropriate.

For more information: www.scai.org

Related Content

Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
Societies Issue New Performance and Quality Measures for Treating Patients with Heart Attack
News | Cath Lab| October 17, 2017
The American College of Cardiology and the American Heart Association recently released updated clinical performance...
First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure| October 17, 2017
October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S.
Dee Dee Wang runs Henry Ford Hospital's 3D printing lab for its complex structural heart cardiology program.

Dee Dee Wang, M.D., runs Henry Ford Hospital's 3-D printing lab that supports its complex structural heart program.

Feature | 3-D Printing| October 13, 2017 | Dave Fornell
Three-dimensional (3-D) printed anatomic models created from a patient’s computed tomography (CT), magnetic resonance...
Videos | Chronic Total Occlusion (CTO)| October 09, 2017
Bill Lombardi, M.D., director of complex coronary artery interventions at the University of Washington, discusses the
BTG Acquires Roxwood Medical
News | Business| October 05, 2017
BTG plc announced it has acquired Roxwood Medical, provider of advanced cardiovascular specialty catheters used in the...
TVA Medical Receives CE Mark for Next-Generation EverlinQ 4 EndoAVF System
News | Vascular Access| October 04, 2017
TVA Medical Inc. announced that its everlinQ 4 endoAVF System has received CE Mark in the European Union. The...
Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters| October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
TherOx Gains FDA PMA Approval for SSO2 Therapy System
Technology | Cath Lab| September 29, 2017
September 29, 2017 — TherOx Inc. announced that the U.S.
Avinger Receives CE Mark for In-Stent Restenosis Indication With Pantheris Image-Guided Atherectomy
Technology | Atherectomy Devices| September 29, 2017
Avinger Inc. recently announced Conformité Européenne (CE) Marking approval for treating in-stent restenosis with the...
Overlay Init